"Interest Rate" means a fixed interest rate of 9 per cent, per annum payable semi annually in arrears.
"Issuer" means Primex Pharmaceuticals Oy, business identity code 2333069-4, a company incorporated in Finland.
"Issuing Agent" means Nordea Bank Finland Pic, business identity code 1680235-8, Satamaradankatu 5, 00020 Nordea, Finland, acting as issue agent (Fin: liikkeeseenlaskijan asiamies) of the Bonds for and on behalf of the Issuer, or any other party replacing the same as Issuing Agent in accordance with the regulations of the CSD.
"Liquidity" means the aggregate of the Group's cash and cash equivalent investments.
"Make Whole Amount" shall mean the amount set forth in paragraph (a)(i) of Clause 11.3 (Voluntary Total Redemption).
"Material Adverse Effect" means a material adverse effect on:
(a) the business, financial condition or operations of the Group taken as a whole;
(b) the Issuer's ability to perform and comply with the undertakings set out in Clause 14 (General Undertakings); or
(c) the validity or enforceability of these Terms and Conditions.
